DR. VIVIEN KARL
PrivateLast Round
Pre Seed
May 9, 2023
Total Funding Raised
$1.63M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
DR. VIVIEN KARL operates in Consumer & Commerce and is based in Berlin. Its latest recorded funding round was a Pre Seed round in May 2023.
DR. VIVIEN KARL is a personal products company that develops and sells natural, science-based intimate care products for women.
Sector
Consumer & Commerce
Verticals
D2C Brands, Fashion & Beauty, E-commerce
Business Model
B2C
Customer Profile
Hardware Sales, Hardware + Subscription
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
DR. VIVIEN KARL Comparables
Compare DR. VIVIEN KARL with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| DR. KADE Pharmazeutische Fabrik | 74% | |
| Combe | 67% | |
| fembites GmbH | 66% |
For institutional investors. Book with your work email.
DR. VIVIEN KARL Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Pre Seed | May 9, 2023 | ||||
| Pre Seed | Aug 18, 2022 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
DR. VIVIEN KARL Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| better ventures | Pre Seed |
| Dieter von Holtzbrinck Ventures | Pre Seed |
| Leanox Impact Capital | Pre Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 17, 2026
Open roles increased to 6, 2.5x the trailing average.
- Aug 3, 2026
Open roles increased to 4, 29% of headcount.
For institutional investors. Book with your work email.
DR. VIVIEN KARL Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about DR. VIVIEN KARL's valuation, stock price, and market status.
Is DR. VIVIEN KARL a public or private company?
DR. VIVIEN KARL is a private company.
What is the current stock price of DR. VIVIEN KARL?
DR. VIVIEN KARL is a private company, so its shares have no public market price. Caplight tracks DR. VIVIEN KARL's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is DR. VIVIEN KARL worth (valuation)?
Valuation information for DR. VIVIEN KARL is not publicly available.
Can I buy DR. VIVIEN KARL stock?
DR. VIVIEN KARL shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was DR. VIVIEN KARL's last funding round?
DR. VIVIEN KARL's most recent funding round was Pre Seed on May 9, 2023.
Who are the main investors in DR. VIVIEN KARL?
Key investors in DR. VIVIEN KARL include Dieter von Holtzbrinck Ventures.
Will DR. VIVIEN KARL IPO soon?
No public IPO plans have been announced for DR. VIVIEN KARL.
How can I track DR. VIVIEN KARL secondary market activity?
Caplight tracks bids, offers, and trades in DR. VIVIEN KARL's shares on secondary markets.